NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cadenza Bio

Cadenza Bio

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://www.cadenza.bio/

Last Round

Seed

Dec 14, 2023

Total Funding Raised

$2.44M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cadenza Bio is a biotechnology company that develops novel small-molecule drugs for demyelinating and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall molecule therapeuticspreclinical researchinflammatory diseasefibrotic diseasebiotech startuptherapeutic developmentdrug pipelinebiopharmapreclinical assetsdrug licensingearly-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cadenza Bio Comps

Public and private peers based on sector, stage, and business model.

Cadenza Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cadenza Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 14, 2023

Key People

Founding team and executive leadership

Carol Curtis

Co-Founder CEO

Founding Team

Cadenza Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 210% MoM, reaching 6.4K.

  • Feb 7, 2025

    Partnered with Tufts University to advance endometriosis program.

Cadenza Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cadenza Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cadenza Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range5
Year Founded2022
Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.